Company Overview of Harvard Medical School
Harvard Medical School is an educational institution.
25 Shattuck Street
Boston, MA 02115
Founded in 2005
Key Executives for Harvard Medical School
Chief Information Officer
Compensation as of Fiscal Year 2014.
Harvard Medical School Key Developments
Harvard Medical School Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 08:30 AM
Feb 22 15
Harvard Medical School Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 08:30 AM. Venue: The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St, 40th Floor (D Elevator Bank), New York, NY10007, United States. Speakers: Barrett J. Rollins, MD, PhD, Linde Family Professor of Medicine.
Harvard Medical School's New England Primate Research Center to Cut 45 Jobs
Dec 11 14
About 45 employees at Harvard Medical School's New England Primate Research Center are scheduled to be laid off next month, in the first round of significant job eliminations at the facility. Harvard Medical School representatives announced about 18 months ago that operations at the center would wind down and it would close by 2015. The facility had come under fire by animal rights groups that protested outside the facility on several occasions and the U.S. Department of Agriculture after several monkeys died between June 2010 and February 2012 because of inadequate care.
Astellas Pharma, Inc. Announces Research Collaboration with Harvard Medical School
Oct 16 14
Astellas Pharma Inc. has announced a research collaboration with an investigator at Harvard Medical School to discover the pathologic mechanism for retinitis pigmentosa and identification of new therapeutic targets. Astellas and Harvard will work with the aim to provide a new treatment option with a view of a gene therapy, to retinitis pigmentosa patients who have difficulty maintaining good vision. Using adeno-associated virus vectors, genes that prolong vision in those who inherit retinitis pigmentosa will be identified and verified. Astellas will support the collaboration for up to three years. If the collaboration is successful in identifying genes that lead to promising treatment options for patients, Astellas will conduct further drug discovery on such promising candidates, and subsequent development and commercialization under an exclusive license from Harvard.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries